![discount label](https://static.cymitquimica.com/public/img/discount.png)
4-[(4-Chlorophenyl)amino]-4-oxobutanoic acid
CAS: 17722-52-0
Ref. 3D-FC126496
1g | To inquire | ||
2g | To inquire | ||
5g | To inquire | ||
10g | To inquire | ||
500mg | To inquire |
Product Information
- butanoic acid
- 4-[(4-chlorophenyl)amino]-4-oxo-
- Butanoic Acid, 4-[(4-Chlorophenyl)Amino]-4-Oxo-
4-[(4-Chlorophenyl)amino]-4-oxobutanoic acid is a hydroxylated metabolite of ocrelizumab, a humanized monoclonal antibody that targets CD20. 4-[(4-Chlorophenyl)amino]-4-oxobutanoic acid inhibits the proliferation of lymphocytes and macrophages, which is caused by its ability to inhibit the production of proinflammatory cytokines. This drug has been shown to be effective for the treatment of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. It also has beneficial effects on body mass index and disease activity in patients with these diseases.
Chemical properties
Technical inquiry about: 3D-FC126496 4-[(4-Chlorophenyl)amino]-4-oxobutanoic acid
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.